CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 6. Expression of mRNA for endophilin-I and CtBP/BARS in Jurkat cells or in the sublines. Total RNA (1 µg) was obtained from Jurkat, Jurkat-ws, or Jurkat-hp cells, reversed transcribed, and the resulting cDNA subjected to PCR. Endophilin-I and CtBP/BARS fragments of 716 bp or 239 bp, respectively, were amplified and separated in agarose gels, as indicated. The same protocol was used to amplify a ß-actin fragment from the same samples, used as a loading control in the bottom panel. The experiment shown is representative of five different experiments.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation